Bill Ackman finally bought some Valeant stock
Activist investor Bill Ackman, the CEO of $20 billion Pershing Square Capital, now owns a $3.3 billion stake in Valeant Pharmaceuticals, Reuters' Svea Herbst-Bayliss reports citing an unnamed source.
According to Reuters, Ackman owns an approximately 5% passive stake in the Canadian drug company. He started building the position this year.
Last year, Ackman teamed up with Valeant to pursue a hostile takeover of Allergan, the maker of Botox. All of Ackman and Valeant's offers were rejected.
At the time, Ackman didn't own any shares of Valeant. According to Reuters, he couldn't own Valeant shares while they were working on the takeover together.
Ackman made more than $2.28 billion on his position in Allergan after the company was acquired by Actavis in a $66 billion deal.
Shares of Valeant were last trading up about 2.07% at $202.91 per share.
Yahoo! Finance
- RBI Governor Das discusses ways to scale up UPI ecosystem with stakeholders
- People find ChatGPT to have a better moral compass than real humans, study reveals
- TVS Motor Company net profit rises 15% to ₹387 crore in March quarter
- Canara Bank Q4 profit rises 18% to ₹3,757 crore
- Indegene IPO allotment – How to check allotment, GMP, listing date and more
- Nothing Phone (2a) blue edition launched
- JNK India IPO allotment date
- JioCinema New Plans
- Realme Narzo 70 Launched
- Apple Let Loose event
- Elon Musk Apology
- RIL cash flows
- Charlie Munger
- Feedbank IPO allotment
- Tata IPO allotment
- Most generous retirement plans
- Broadcom lays off
- Cibil Score vs Cibil Report
- Birla and Bajaj in top Richest
- Nestle Sept 2023 report
- India Equity Market